University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
University of Texas Southwestern Medical Center, Dallas, Texas.
J Urol. 2017 May;197(5):1280-1288. doi: 10.1016/j.juro.2016.11.097. Epub 2016 Nov 23.
WISQOL (Wisconsin Stone Quality of Life questionnaire) is a disease specific, health related quality of life measure designed for patients who form kidney stones. The purpose of this study was to demonstrate the external and convergent validity of WISQOL and assess its psychometric properties.
At the WISQOL creation site (development sample) and at 8 geographically diverse centers in the United States and Canada (consortium sample) patients with a history of kidney stones were recruited. Item response option variability, correlation patterns and internal consistency were compared between samples. Convergent validity was assessed by patients who completed both WISQOL and SF-36v2® (36-Item Short Form Health Survey, version 2).
Results were analyzed in 1,609 patients, including 275 in the development sample and 1,334 in the consortium sample. Response option variability patterns of all items were acceptable. Internal WISQOL consistency was acceptable. Intersample score comparisons revealed few differences. For both samples the domain-total WISQOL score correlations exceeded 0.86. Item level analyses demonstrated suitable variation, allowing for discriminatory scoring. At the time that they completed WISQOL, patients with stones and stone related symptoms scored lowest for health related quality of life. Patients with stones but no symptoms and those with no stones scored higher. The convergent validity substudy confirmed the ability of WISQOL to identify stone specific decrements in health related quality of life that were not identified on SF-36v2.
WISQOL is internally consistent and discriminates among patients with different stone statuses and symptoms. WISQOL is externally valid across the North American population. It may be used for multicenter health related quality of life studies in kidney stone disease.
WISQOL(威斯康星结石生活质量问卷)是一种针对肾结石患者的特定于疾病的健康相关生活质量测量工具。本研究的目的是证明 WISQOL 的外部和收敛有效性,并评估其心理测量特性。
在 WISQOL 创建地点(开发样本)和美国和加拿大 8 个地理位置不同的中心(联盟样本)招募有肾结石病史的患者。在样本之间比较项目反应选项的可变性、相关模式和内部一致性。通过同时完成 WISQOL 和 SF-36v2®(36 项简短健康调查,第 2 版)的患者评估收敛有效性。
对 1609 名患者进行了分析,包括开发样本中的 275 名和联盟样本中的 1334 名。所有项目的反应选项可变性模式都是可以接受的。WISQOL 的内部一致性是可以接受的。样本间得分比较显示差异很小。对于两个样本,域总分 WISQOL 得分相关性均超过 0.86。项目水平分析表明,有足够的变化,可以进行区分评分。在完成 WISQOL 的同时,有结石和结石相关症状的患者的健康相关生活质量得分最低。没有症状的结石患者和没有结石的患者得分较高。收敛有效性子研究证实,WISQOL 能够识别出与健康相关的生活质量的特定下降,而这些下降在 SF-36v2 中并未被识别。
WISQOL 具有内部一致性,可以区分不同结石状态和症状的患者。WISQOL 在北美人群中具有外部有效性。它可用于肾结石疾病的多中心健康相关生活质量研究。